Combining CT, FDG-PET provides more accurate treatments for head and neck cancer patients

	Tweet

Combining computerized tomography (CT) with fluorodeoxyglucose positron emission tomography (FDG-PET) images results in significantly more defined tumor outlines and potentially different treatment options in head and neck cancer patients compared to using CT alone, according to research presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).

CT is the standard method for determining tumor delineation before deciding head and neck cancer treatment - typically intensity modulated radiation therapy. However, FDG-PET is an imaging method that uses a radioactive product combined with sugar and can produce better defined outlines of the tumor.

Researchers sought to determine the significance of combining CT and FDG-PET when determining tumor delineation and treatment for head and neck cancer patients. 

In this trial, 327 patients were treated with IMRT for head and neck cancer. Based on the combined approach of the CT-scan and FDG-PET, the researchers noticed a change in the delineation of the tumor in one out of three patients, resulting in 10 percent of patients’ treatment being changed and 33 percent of patients having their treatment adjusted.

In 17 percent of the patients, the primary tumor was not visible on the CT-scan alone, mostly due to dental inlays.

“We expected there to be an improved delineation of the tumor,” Homan Dehnad, MD, a study author and radiation oncologist at Utrecht University Medical Center in Utrecht, Netherlands, said. “However, we never expected it to have such an influence on the treatment options for patients. Each dedicated institute dealing with head and neck cancer should be equipped with multi-imaged facilities.”

###

The abstract, “Significance of the Use of FDG-PET Combined with CT for Tumour Delineation in Primary Radiotherapy for Head and Neck Cancer,” will be presented at 4:30 p.m. Eastern time on April 29, 2011. To speak with Homan Dehnad, MD, please call Beth Bukata or Lisa Gibson on April 29, 2011, in the press office, Room M102, at the Atlanta Marriott Marquis at 404-586-6270. You may also email them at or .

###

Contact: Beth Bukata

American Society for Radiation Oncology

RELATED STORIES:
Antidepressant may help head/neck cancer patients   Study Compares Treatment Options for Patients with Brain Metastases   Does Green Tea Prevent Cancer? Evidence Continues to Brew, But Questions Remain   Cancer sequencing initiative discovers mutations tied to aggressive childhood brain tumors   Alcohol and cancer: is drinking the new smoking?   Protein Expression Holds Promise for Head and Neck Cancer Detection   Immune deficiency linked to a type of eye cancer   Coffee may cut risk of head and neck cancers   Researchers Pinpoint Origin of Deadly Brain Tumor   Sensitizing tumor response to cancer therapy   Sex virus blamed for rise in head and neck cancers   Radiotherapy Advance Builds Hope for Noninvasive Brain Cancer Treatment   ‘Timing is everything’ in ensuring healthy brain development   Could smoking pot cut risk of head, neck cancer?   Researchers Identify Genetic Markers for Aggressive Head and Neck Cancer   Blue light used to harden tooth fillings stunts tumor growth   Dental X-rays May Raise Risk of Brain Cancer   Venom protein may lead to brain cancer cure   Brain Cancer Experts and Resources at Johns Hopkins   Gene therapy increases survival for end-stage head and neck cancer   Non-invasive imaging can detect mutations within a brain tumor   Psychiatric symptoms can be first sign of cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]